SHINGRIX is a shingles vaccine for those aged 50 years and older. Find dosing details, administration tips, and more
SHINGRIX is a shingles vaccine for those aged 50 years and older. Find dosing details, administration tips, and more
SHINGRIX is a shingles vaccine for those aged 50 years and older. Find dosing details, administration tips, and more
SHINGRIX is a shingles vaccine for those aged 50 years and older. Find dosing details, administration tips, and more
GlaxoSmithKline plc [LSE/NYSE: GSK] today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 50 years and older. Shingrix is a non-live, recombi...
GlaxoSmithKline plc announced that the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend two doses of Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) and its complica...
Recommend SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted) to your patients 50 years of age and older at their next visit.1 Meet Jennifer* She's healthy, and still at risk of shingles** Who is Jennifer? Married, self-employed, takes care of her children and is very active in her...
A STRONG RECOMMENDATION FOR SHINGRIX STARTS WITH YOU Learn how to start the conversation SEE 3-STEP PLAN Indication Important Safety Information SHINGRIX is a vaccine indicated for prevention of herpes zoster (HZ) (shingles): in adults aged 50 years and older. ...